NCT07238712: Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
- State
- Under way
- Phase
- Phase 2
- People
- 80 planned
- Started
- 10 May 2025
- Primary completion
- 10 Dec 2027
- Arms
- Experimental: Test cohort 1 - ruxolitinib
- Results
- None posted
- 10 May 2025: Trial started
- 20 Nov 2025: Trial registered